6185.HK

CanSino Biologics Inc. [6185.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

6185.HK Stock Summary

Top 10 Correlated ETFs

6185.HK


Top 10 Correlated Stocks

6185.HK


In the News

6185.HK Financial details

Company Rating
Buy
Market Cap
12.34B
Income
-275.76M
Revenue
6.03M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.95K
Optionable
No
Shortable
Yes
Earnings
30 Aug 2023
P/E
-5.82
Forward P/E
490
PEG
0.56
P/S
11.49
P/B
0.83
P/C
-
P/FCF
-4
Quick Ratio
2.02
Current Ratio
2.63
Debt / Equity
0.4
LT Debt / Equity
0.16
-
-
EPS (TTM)
-0.34
EPS next Y
0.05
EPS next Q
-
EPS this Y
-150.52%
EPS next Y
-115.6%
EPS next 5Y
-115.6%
EPS last 5Y
44.07%
Revenue last 5Y
290.74%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
1.08%
SMA50
-6.81%
SMA100
-32.96%
Inst Own
0%
Inst Trans
0%
ROA
-8%
ROE
-13%
ROC
-0.16%
Gross Margin
-18%
Oper. Margin
-133%
Profit Margin
-94%
Payout
-20%
Shs Outstand
521.1M
Shs Float
128.55M
-
-
-
-
Target Price
-
52W Range
22.2-147.5
52W High
-83.33%
52W Low
+11.36%
RSI
49.89
Rel Volume
0.06
Avg Volume
2.5M
Volume
155.37K
Perf Week
1.66%
Perf Month
-3.54%
Perf Quarter
-40.89%
Perf Half Y
-45.74%
-
-
-
-
Beta
0.678662
-
-
Volatility
0.58%, 0.66%
Prev Close
-2%
Price
24.5
Change
-1.8%

6185.HK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
0.010.010.0817.384.17
Net income per share
-0.63-0.75-1.557.74-3.91
Operating cash flow per share
-0.57-0.84-2.038.14-7.64
Free cash flow per share
-1.3-1.41-3.213.28-11.99
Cash per share
0.93.7122.1531.4524.07
Book value per share
2.37.2326.2932.3127.32
Tangible book value per share
2.076.9525.9833.7428.28
Share holders equity per share
2.37.2326.2932.3127.32
Interest debt per share
0.690.820.625.6411.1
Market cap
6.59B10.7B34.19B36.39B14.71B
Enterprise value
6.69B10.66B29.89B32.31B14.01B
P/E ratio
-47.68-69.87-95.3819.01-15.24
Price to sales ratio
5.82K4.68K1.84K8.4614.26
POCF ratio
-53.32-62.86-72.8518.06-7.79
PFCF ratio
-23.19-37.26-46.244.85-4.96
P/B Ratio
13.137.275.634.552.18
PTB ratio
13.137.275.634.552.18
EV to sales
5.91K4.67K1.61K7.5113.59
Enterprise value over EBITDA
-48.17-77.29-74.1716.34-13.61
EV to operating cash flow
-54.07-62.65-63.6816.04-7.42
EV to free cash flow
-23.51-37.13-40.3839.82-4.73
Earnings yield
-0.02-0.01-0.010.05-0.07
Free cash flow yield
-0.04-0.03-0.020.02-0.2
Debt to equity
0.30.110.020.170.4
Debt to assets
0.190.090.020.120.24
Net debt to EBITDA
-0.670.2610.68-2.060.67
Current ratio
2.076.3913.133.232.63
Interest coverage
00093.62-33.11
Income quality
0.891.091.151.061.59
Dividend Yield
00000.01
Payout ratio
-0.05-0.0600-0.2
Sales general and administrative to revenue
18.227.54.470.050.27
Research and developement to revenue
100.3966.4623.110.20.75
Intangibles to total assets
0.060.030.010.020.02
Capex to operating cash flow
1.30.690.58-0.60.57
Capex to revenue
-141.94-51.22-14.6-0.28-1.04
Capex to depreciation
-13.37-5.2-8.51-13.59-5.47
Stock based compensation to revenue
13.949.420.9400.01
Graham number
5.7311.0630.374.9949
ROIC
-0.19-0.12-0.060.2-0.12
Return on tangible assets
-0.19-0.09-0.050.16-0.09
Graham Net
-0.892.2719.5819.788.35
Working capital
114.32M669.95M5.01B6.41B4.79B
Tangible asset value
451.06M1.41B6B8.35B6.99B
Net current asset value
-72.55M480.26M4.74B5.96B3.51B
Invested capital
0.30.110.020.170.4
Average receivables
-201.16M-58.82M8.95M00
Average payables
4.27M6.41M33.37M451.57M547.84M
Average inventory
5.06M12.42M93.43M523.07M776.7M
Days sales outstanding
-43.71K2.86K000
Days payables outstanding
21.3615.27K1.6K237.2175.87
Days of inventory on hand
27.2840.44K4.51K246.51203.17
Receivables turnover
-0.010.13000
Payables turnover
17.090.020.231.544.81
Inventory turnover
13.380.010.081.481.8
ROE
-0.28-0.1-0.060.24-0.14
Capex per share
-0.74-0.57-1.17-4.86-4.35

Quarterly Fundamentals Overview

Last date of statement is 2022-12-31 for Q4

Metric History 2020-12-312021-06-302021-12-312022-06-30 2022-12-31
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
00000
Tangible book value per share
00000
Share holders equity per share
00000
Interest debt per share
00000
Market cap
00000
Enterprise value
-4.3B-3.59B-4.08B-1.62B-694.19M
P/E ratio
00000
Price to sales ratio
00000
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
00000
PTB ratio
00000
EV to sales
00000
Enterprise value over EBITDA
00000
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
0.020.130.170.280.4
Debt to assets
0.020.090.120.180.24
Net debt to EBITDA
00000
Current ratio
13.132.923.232.992.63
Interest coverage
00000
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.010.010.020.010.02
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
00000
ROIC
00000
Return on tangible assets
00000
Graham Net
00000
Working capital
5.01B5.41B6.41B5.99B4.79B
Tangible asset value
6B6.92B8.35B8.14B6.99B
Net current asset value
4.74B4.99B5.96B5.27B3.51B
Invested capital
0.020.130.170.280.4
Average receivables
00000
Average payables
35.42M0000
Average inventory
115.74M0000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
00000
Capex per share
00000

6185.HK Frequently Asked Questions

What is CanSino Biologics Inc. stock symbol ?

CanSino Biologics Inc. is a CN stock and trading under the symbol 6185.HK

What is CanSino Biologics Inc. stock quote today ?

CanSino Biologics Inc. stock price is $24.5 today.

Is CanSino Biologics Inc. stock public?

Yes, CanSino Biologics Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks